Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 61 | 2023 | 6754 | 3.690 |
Why?
|
Carcinoma, Pancreatic Ductal | 16 | 2024 | 1631 | 2.050 |
Why?
|
Pancreatic Neoplasms | 26 | 2024 | 5249 | 1.790 |
Why?
|
Tumor Microenvironment | 23 | 2023 | 3564 | 1.530 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 13 | 2022 | 1038 | 1.500 |
Why?
|
Adenocarcinoma | 17 | 2024 | 6347 | 1.410 |
Why?
|
Microsatellite Instability | 23 | 2023 | 678 | 1.370 |
Why?
|
Fusobacterium nucleatum | 9 | 2021 | 160 | 1.080 |
Why?
|
DNA Mismatch Repair | 8 | 2023 | 424 | 1.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 14 | 2023 | 2028 | 0.780 |
Why?
|
Genes, erbB-2 | 1 | 2020 | 162 | 0.710 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 4 | 2019 | 379 | 0.700 |
Why?
|
Granulocytes | 1 | 2021 | 546 | 0.680 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 315 | 0.650 |
Why?
|
Receptor, IGF Type 1 | 1 | 2020 | 390 | 0.620 |
Why?
|
Prognosis | 26 | 2023 | 29010 | 0.510 |
Why?
|
High-Throughput Nucleotide Sequencing | 9 | 2023 | 3585 | 0.490 |
Why?
|
DNA Mutational Analysis | 6 | 2022 | 4187 | 0.470 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 10 | 2023 | 1683 | 0.470 |
Why?
|
Colonic Neoplasms | 7 | 2023 | 2542 | 0.460 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2023 | 602 | 0.440 |
Why?
|
Pathology, Molecular | 4 | 2019 | 325 | 0.420 |
Why?
|
Cell Lineage | 2 | 2020 | 2504 | 0.410 |
Why?
|
Monocytes | 1 | 2021 | 2593 | 0.400 |
Why?
|
Mutation | 32 | 2023 | 29717 | 0.380 |
Why?
|
DNA, Bacterial | 5 | 2018 | 1465 | 0.370 |
Why?
|
DNA Methylation | 14 | 2024 | 4282 | 0.360 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2723 | 0.360 |
Why?
|
Hair Follicle | 2 | 2009 | 209 | 0.350 |
Why?
|
Fusobacterium Infections | 2 | 2021 | 53 | 0.350 |
Why?
|
Prospective Studies | 32 | 2024 | 53187 | 0.330 |
Why?
|
Diet | 8 | 2022 | 7923 | 0.320 |
Why?
|
Humans | 117 | 2024 | 742088 | 0.300 |
Why?
|
Helicobacter pylori | 2 | 2023 | 381 | 0.300 |
Why?
|
Cyclooxygenase 2 | 3 | 2020 | 611 | 0.290 |
Why?
|
Stem Cells | 3 | 2009 | 3563 | 0.280 |
Why?
|
CpG Islands | 5 | 2023 | 1170 | 0.280 |
Why?
|
Receptors, Calcium-Sensing | 2 | 2017 | 315 | 0.270 |
Why?
|
Myeloid Cells | 2 | 2020 | 804 | 0.270 |
Why?
|
Calcium, Dietary | 2 | 2019 | 527 | 0.260 |
Why?
|
Aged | 52 | 2024 | 162944 | 0.260 |
Why?
|
Tumor Escape | 2 | 2018 | 349 | 0.250 |
Why?
|
Germ-Line Mutation | 6 | 2022 | 1786 | 0.250 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2024 | 4438 | 0.250 |
Why?
|
Carcinoma | 4 | 2017 | 2374 | 0.240 |
Why?
|
Middle Aged | 53 | 2024 | 213127 | 0.230 |
Why?
|
Proportional Hazards Models | 12 | 2022 | 12344 | 0.220 |
Why?
|
Phenotype | 10 | 2023 | 16331 | 0.220 |
Why?
|
Cell Separation | 1 | 2009 | 1749 | 0.220 |
Why?
|
Follow-Up Studies | 23 | 2024 | 39004 | 0.220 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 644 | 0.210 |
Why?
|
Iron-Sulfur Proteins | 1 | 2022 | 82 | 0.210 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1837 | 0.210 |
Why?
|
Male | 59 | 2024 | 349538 | 0.210 |
Why?
|
Rectal Neoplasms | 3 | 2016 | 1195 | 0.210 |
Why?
|
Helicobacter Infections | 2 | 2023 | 385 | 0.210 |
Why?
|
Leukocytes | 2 | 2021 | 2039 | 0.210 |
Why?
|
Keloid | 1 | 2022 | 50 | 0.200 |
Why?
|
Female | 62 | 2024 | 379592 | 0.200 |
Why?
|
Epithelial Cells | 3 | 2009 | 3678 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 4 | 2023 | 4553 | 0.200 |
Why?
|
DNA Glycosylases | 1 | 2022 | 128 | 0.200 |
Why?
|
Staining and Labeling | 2 | 2020 | 1099 | 0.190 |
Why?
|
Colitis | 2 | 2020 | 1149 | 0.190 |
Why?
|
Long Interspersed Nucleotide Elements | 3 | 2020 | 338 | 0.190 |
Why?
|
Alkylating Agents | 1 | 2021 | 139 | 0.190 |
Why?
|
Lymphocytes | 3 | 2020 | 2614 | 0.190 |
Why?
|
Weight Loss | 2 | 2024 | 2604 | 0.190 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 6 | 2022 | 890 | 0.190 |
Why?
|
Hematoxylin | 1 | 2020 | 64 | 0.190 |
Why?
|
Kaplan-Meier Estimate | 7 | 2020 | 6534 | 0.190 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 72 | 0.190 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2004 | 555 | 0.180 |
Why?
|
Autophagy | 3 | 2022 | 1301 | 0.180 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2021 | 187 | 0.180 |
Why?
|
Survival Analysis | 8 | 2020 | 10248 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9185 | 0.180 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2021 | 224 | 0.180 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2505 | 0.180 |
Why?
|
Receptors, Chemokine | 2 | 2020 | 669 | 0.180 |
Why?
|
T-Lymphocytes | 6 | 2023 | 10163 | 0.170 |
Why?
|
Lymphocyte Count | 5 | 2022 | 792 | 0.170 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 48 | 0.170 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 319 | 0.170 |
Why?
|
Bifidobacteriales Infections | 1 | 2018 | 10 | 0.170 |
Why?
|
Paraffin Embedding | 1 | 2020 | 299 | 0.170 |
Why?
|
Tissue Fixation | 1 | 2020 | 241 | 0.170 |
Why?
|
Lysine | 1 | 2023 | 1008 | 0.170 |
Why?
|
Immunohistochemistry | 8 | 2021 | 11363 | 0.160 |
Why?
|
Microsatellite Repeats | 2 | 2021 | 800 | 0.160 |
Why?
|
Formaldehyde | 1 | 2020 | 353 | 0.160 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 532 | 0.160 |
Why?
|
Intestine, Small | 2 | 2021 | 1243 | 0.160 |
Why?
|
Ribonuclease III | 1 | 2020 | 275 | 0.160 |
Why?
|
Bifidobacterium | 1 | 2018 | 100 | 0.160 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2018 | 83 | 0.160 |
Why?
|
Sarcoma | 2 | 2020 | 1895 | 0.160 |
Why?
|
Neoadjuvant Therapy | 3 | 2023 | 2721 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 563 | 0.150 |
Why?
|
Forkhead Transcription Factors | 3 | 2020 | 1613 | 0.150 |
Why?
|
Neoplasms | 8 | 2024 | 21596 | 0.150 |
Why?
|
Macrophage Activation | 1 | 2020 | 558 | 0.150 |
Why?
|
Colon | 3 | 2020 | 1773 | 0.150 |
Why?
|
DEAD-box RNA Helicases | 1 | 2020 | 375 | 0.150 |
Why?
|
Osteosarcoma | 1 | 2023 | 880 | 0.150 |
Why?
|
Coffee | 1 | 2022 | 578 | 0.150 |
Why?
|
Jews | 1 | 2019 | 385 | 0.150 |
Why?
|
Dairy Products | 1 | 2021 | 498 | 0.150 |
Why?
|
Gene Expression Regulation, Neoplastic | 8 | 2023 | 8425 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 1434 | 0.140 |
Why?
|
Feeding Behavior | 2 | 2021 | 3187 | 0.140 |
Why?
|
Epidemiology | 1 | 2019 | 287 | 0.140 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2019 | 241 | 0.140 |
Why?
|
Molecular Epidemiology | 4 | 2019 | 468 | 0.140 |
Why?
|
Lymph Nodes | 2 | 2017 | 3465 | 0.130 |
Why?
|
Bile Duct Neoplasms | 1 | 2021 | 567 | 0.130 |
Why?
|
Cholangiocarcinoma | 1 | 2021 | 516 | 0.130 |
Why?
|
Pathology Department, Hospital | 1 | 2015 | 10 | 0.130 |
Why?
|
Neuroendocrine Tumors | 1 | 2021 | 594 | 0.130 |
Why?
|
Mullerian Ducts | 1 | 2016 | 198 | 0.130 |
Why?
|
Immunotherapy | 3 | 2021 | 4414 | 0.130 |
Why?
|
Incidence | 11 | 2022 | 20928 | 0.130 |
Why?
|
Adult | 32 | 2021 | 213712 | 0.130 |
Why?
|
Medical History Taking | 1 | 2019 | 783 | 0.130 |
Why?
|
Pathology, Clinical | 2 | 2015 | 368 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 987 | 0.120 |
Why?
|
Genes, Neoplasm | 1 | 2016 | 376 | 0.120 |
Why?
|
Skin | 1 | 2008 | 4353 | 0.120 |
Why?
|
Aspirin | 2 | 2017 | 3278 | 0.120 |
Why?
|
Calcium Signaling | 1 | 2019 | 721 | 0.120 |
Why?
|
Gastric Mucosa | 1 | 1997 | 598 | 0.120 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2020 | 642 | 0.120 |
Why?
|
Body Composition | 1 | 2023 | 2400 | 0.120 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 199 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 6 | 2022 | 17400 | 0.120 |
Why?
|
Laboratories, Hospital | 1 | 2015 | 194 | 0.120 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2699 | 0.120 |
Why?
|
Rectum | 2 | 2019 | 903 | 0.120 |
Why?
|
Utilization Review | 1 | 2015 | 392 | 0.110 |
Why?
|
Protein Interaction Mapping | 1 | 2017 | 627 | 0.110 |
Why?
|
Seafood | 1 | 2016 | 384 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 324 | 0.110 |
Why?
|
Metabolome | 1 | 2020 | 881 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1359 | 0.110 |
Why?
|
United States | 12 | 2021 | 69693 | 0.110 |
Why?
|
Oncogenes | 1 | 2019 | 1263 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2018 | 3239 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2133 | 0.110 |
Why?
|
Cost Control | 1 | 2015 | 624 | 0.110 |
Why?
|
Disease-Free Survival | 5 | 2023 | 6891 | 0.100 |
Why?
|
Up-Regulation | 2 | 2019 | 4211 | 0.100 |
Why?
|
Phagocytosis | 1 | 2017 | 1538 | 0.100 |
Why?
|
Central Nervous System Neoplasms | 1 | 2020 | 895 | 0.100 |
Why?
|
Lymph Node Excision | 1 | 2017 | 1248 | 0.100 |
Why?
|
Bone Neoplasms | 1 | 2023 | 2522 | 0.090 |
Why?
|
Macrophages | 3 | 2023 | 5655 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2015 | 712 | 0.090 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 663 | 0.090 |
Why?
|
Adenoma | 1 | 2021 | 2168 | 0.090 |
Why?
|
Pancreatectomy | 3 | 2020 | 802 | 0.090 |
Why?
|
MicroRNAs | 2 | 2016 | 3731 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 2276 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2019 | 1327 | 0.090 |
Why?
|
Integrin alpha6 | 1 | 2009 | 30 | 0.090 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2013 | 0.080 |
Why?
|
Ubiquitins | 2 | 2000 | 383 | 0.080 |
Why?
|
Multivariate Analysis | 6 | 2017 | 12242 | 0.080 |
Why?
|
Mitomycin | 1 | 2009 | 259 | 0.080 |
Why?
|
Gene Expression Profiling | 3 | 2019 | 9410 | 0.080 |
Why?
|
Germ Cells | 2 | 2022 | 628 | 0.080 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1581 | 0.080 |
Why?
|
Alleles | 1 | 2019 | 6931 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2018 | 2658 | 0.080 |
Why?
|
SOX9 Transcription Factor | 1 | 2008 | 146 | 0.080 |
Why?
|
Computational Biology | 2 | 2017 | 3518 | 0.080 |
Why?
|
High Mobility Group Proteins | 1 | 2008 | 187 | 0.080 |
Why?
|
Cohort Studies | 9 | 2021 | 40450 | 0.080 |
Why?
|
Skin Physiological Phenomena | 1 | 2008 | 180 | 0.080 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3691 | 0.080 |
Why?
|
Cells, Cultured | 4 | 2020 | 19223 | 0.070 |
Why?
|
Risk Factors | 12 | 2022 | 72145 | 0.070 |
Why?
|
3T3 Cells | 1 | 2009 | 1101 | 0.070 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2016 | 1341 | 0.070 |
Why?
|
Aged, 80 and over | 10 | 2021 | 57683 | 0.070 |
Why?
|
Antigens, CD34 | 1 | 2009 | 657 | 0.070 |
Why?
|
Cannabinoids | 1 | 2009 | 166 | 0.070 |
Why?
|
Genomics | 2 | 2023 | 5692 | 0.070 |
Why?
|
Obesity | 2 | 2020 | 12705 | 0.070 |
Why?
|
Mice | 9 | 2023 | 81045 | 0.070 |
Why?
|
Flow Cytometry | 3 | 2020 | 5975 | 0.070 |
Why?
|
Body Mass Index | 3 | 2020 | 12695 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5724 | 0.070 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2183 | 0.070 |
Why?
|
Calcium | 1 | 2019 | 5753 | 0.070 |
Why?
|
Integrases | 1 | 2008 | 533 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2274 | 0.070 |
Why?
|
Cell Nucleus | 1 | 2015 | 2968 | 0.070 |
Why?
|
Pancreas | 2 | 2024 | 1684 | 0.070 |
Why?
|
Base Sequence | 1 | 2016 | 12797 | 0.060 |
Why?
|
DNA Copy Number Variations | 3 | 2019 | 1940 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3070 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15056 | 0.060 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5522 | 0.060 |
Why?
|
Morphogenesis | 1 | 2008 | 752 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5163 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2021 | 2938 | 0.060 |
Why?
|
Tumor Suppressor Protein p14ARF | 1 | 2004 | 90 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2021 | 9274 | 0.060 |
Why?
|
CA-19-9 Antigen | 1 | 2024 | 111 | 0.060 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2024 | 2524 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1144 | 0.060 |
Why?
|
Cell Differentiation | 2 | 2017 | 11470 | 0.060 |
Why?
|
Genetic Variation | 1 | 2018 | 6540 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2410 | 0.050 |
Why?
|
bcl-2-Associated X Protein | 1 | 2004 | 295 | 0.050 |
Why?
|
Blood Glucose | 1 | 2017 | 6249 | 0.050 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2022 | 59 | 0.050 |
Why?
|
Claudins | 1 | 2023 | 111 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6575 | 0.050 |
Why?
|
Allosteric Regulation | 1 | 2023 | 408 | 0.050 |
Why?
|
Sulfur | 1 | 2022 | 166 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11472 | 0.050 |
Why?
|
Biological Availability | 1 | 2022 | 396 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 256 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 203 | 0.050 |
Why?
|
Neoplasm Staging | 4 | 2019 | 11001 | 0.050 |
Why?
|
Databases, Factual | 4 | 2019 | 7716 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4249 | 0.050 |
Why?
|
Animals | 9 | 2023 | 168561 | 0.050 |
Why?
|
Intention | 1 | 2024 | 338 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 173 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 463 | 0.050 |
Why?
|
Endocrine Cells | 1 | 2020 | 10 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 704 | 0.050 |
Why?
|
Exocrine Glands | 1 | 2020 | 50 | 0.050 |
Why?
|
DNA Repair | 2 | 2021 | 2042 | 0.050 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2000 | 1884 | 0.050 |
Why?
|
Cysteine Endopeptidases | 2 | 2000 | 563 | 0.050 |
Why?
|
Signal Transduction | 2 | 2020 | 23387 | 0.050 |
Why?
|
Muscular Atrophy | 1 | 2023 | 350 | 0.050 |
Why?
|
Vacuoles | 1 | 2000 | 230 | 0.040 |
Why?
|
Cell Cycle | 1 | 2008 | 2964 | 0.040 |
Why?
|
Ferritins | 1 | 2022 | 590 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2023 | 581 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11039 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2020 | 2940 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2005 | 1363 | 0.040 |
Why?
|
Multienzyme Complexes | 2 | 2000 | 686 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2008 | 1618 | 0.040 |
Why?
|
Fungal Proteins | 2 | 2000 | 912 | 0.040 |
Why?
|
Receptors, CXCR3 | 1 | 2020 | 237 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4823 | 0.040 |
Why?
|
beta Catenin | 2 | 2020 | 1058 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 2 | 2000 | 2749 | 0.040 |
Why?
|
Survival Rate | 3 | 2018 | 12773 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2005 | 1782 | 0.040 |
Why?
|
MutS Homolog 2 Protein | 1 | 2019 | 200 | 0.040 |
Why?
|
Nurses | 2 | 2019 | 2459 | 0.040 |
Why?
|
Rectus Abdominis | 1 | 2019 | 94 | 0.040 |
Why?
|
Gene Amplification | 1 | 2023 | 1062 | 0.040 |
Why?
|
ras Proteins | 1 | 2023 | 1060 | 0.040 |
Why?
|
Urease | 1 | 1997 | 41 | 0.040 |
Why?
|
Transcription Factors | 3 | 2022 | 12164 | 0.040 |
Why?
|
Cell Line | 2 | 2020 | 15994 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8829 | 0.040 |
Why?
|
Young Adult | 5 | 2021 | 56350 | 0.040 |
Why?
|
beta 2-Microglobulin | 1 | 2018 | 315 | 0.040 |
Why?
|
Histological Techniques | 1 | 1997 | 198 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2023 | 1170 | 0.040 |
Why?
|
Health Personnel | 2 | 2024 | 3210 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2021 | 16665 | 0.040 |
Why?
|
Wound Healing | 1 | 2008 | 2781 | 0.040 |
Why?
|
Colony Count, Microbial | 1 | 1997 | 331 | 0.040 |
Why?
|
Endopeptidases | 1 | 2000 | 772 | 0.040 |
Why?
|
Multigene Family | 1 | 2020 | 1102 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2024 | 1820 | 0.040 |
Why?
|
Allergy and Immunology | 1 | 2018 | 169 | 0.030 |
Why?
|
Cell Division | 1 | 2004 | 4564 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4379 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 954 | 0.030 |
Why?
|
Endocytosis | 1 | 2000 | 983 | 0.030 |
Why?
|
Ribotyping | 1 | 2015 | 35 | 0.030 |
Why?
|
Kinetics | 1 | 2004 | 6474 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2017 | 14554 | 0.030 |
Why?
|
Problem Solving | 1 | 2018 | 440 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 678 | 0.030 |
Why?
|
Adolescent | 5 | 2021 | 85649 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2790 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1144 | 0.030 |
Why?
|
Risk | 2 | 2019 | 9679 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2924 | 0.030 |
Why?
|
NF-kappa B | 1 | 2024 | 2500 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1179 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.030 |
Why?
|
Glioma | 1 | 2009 | 3388 | 0.030 |
Why?
|
Organ Specificity | 1 | 2019 | 2003 | 0.030 |
Why?
|
Esophagectomy | 1 | 2018 | 447 | 0.030 |
Why?
|
Iron | 1 | 2022 | 1773 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2017 | 503 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1780 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 589 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 553 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2043 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 909 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2004 | 2948 | 0.030 |
Why?
|
Dietary Fiber | 1 | 2017 | 760 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3133 | 0.030 |
Why?
|
Smoking | 2 | 2022 | 8969 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2005 | 6171 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10472 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4664 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2747 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2017 | 974 | 0.030 |
Why?
|
HLA Antigens | 1 | 2018 | 1382 | 0.030 |
Why?
|
Expert Testimony | 1 | 2015 | 356 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3612 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13403 | 0.030 |
Why?
|
Epigenomics | 1 | 2017 | 902 | 0.030 |
Why?
|
Antigen Presentation | 1 | 2017 | 1284 | 0.030 |
Why?
|
Gene Dosage | 1 | 2016 | 1251 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2023 | 3278 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 40054 | 0.020 |
Why?
|
Medical Oncology | 1 | 2023 | 2235 | 0.020 |
Why?
|
Protein Conformation | 1 | 2019 | 4013 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1525 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 2866 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21821 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2022 | 77098 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2616 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
Escherichia coli | 1 | 2022 | 4214 | 0.020 |
Why?
|
Viral Proteins | 1 | 2017 | 1899 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2948 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2017 | 2906 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2017 | 1659 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2009 | 68 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1707 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2023 | 3843 | 0.020 |
Why?
|
Proteome | 1 | 2019 | 1790 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2009 | 205 | 0.020 |
Why?
|
Models, Molecular | 1 | 2019 | 5454 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2018 | 1575 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2017 | 2257 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 40955 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 13029 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2009 | 190 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2023 | 4933 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 898 | 0.020 |
Why?
|
Apoptosis | 2 | 2017 | 9715 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 23320 | 0.020 |
Why?
|
Cause of Death | 1 | 2017 | 3571 | 0.020 |
Why?
|
Caspase 3 | 1 | 2009 | 759 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 2986 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1477 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5519 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2017 | 2723 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2018 | 62966 | 0.020 |
Why?
|
Proteomics | 1 | 2019 | 3618 | 0.020 |
Why?
|
Biopsy | 1 | 2017 | 6756 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7317 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 21719 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8297 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2009 | 1086 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2000 | 1333 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1695 | 0.010 |
Why?
|
Disease Progression | 1 | 2020 | 13256 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2009 | 1114 | 0.010 |
Why?
|
Child | 2 | 2021 | 77478 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9846 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1119 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 14720 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2015 | 3527 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 12071 | 0.010 |
Why?
|
Melanoma | 1 | 2020 | 5462 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3328 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2005 | 1950 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18006 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 3557 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10578 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 2000 | 196 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2009 | 2502 | 0.010 |
Why?
|
Intramolecular Transferases | 1 | 1999 | 15 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35070 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2107 | 0.010 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2000 | 144 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 2015 | 3123 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 5979 | 0.010 |
Why?
|
Polyubiquitin | 1 | 1999 | 67 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2016 | 8925 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1997 | 19862 | 0.010 |
Why?
|
Biopolymers | 1 | 1999 | 189 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2009 | 3800 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4229 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2000 | 13814 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2009 | 3020 | 0.010 |
Why?
|
Phosphorylation | 1 | 2009 | 8436 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2009 | 3444 | 0.010 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2000 | 449 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 18112 | 0.010 |
Why?
|
Mutagenesis | 1 | 2000 | 1263 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2000 | 1802 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20086 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 2837 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2000 | 2257 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2019 | 20774 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 24913 | 0.010 |
Why?
|
Algorithms | 1 | 2015 | 13853 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 6096 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35342 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9581 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2000 | 6608 | 0.010 |
Why?
|
Genotype | 1 | 2000 | 12946 | 0.000 |
Why?
|